Control of mammary stem cell function by steroid hormone signalling.
The ovarian hormones oestrogen and progesterone profoundly influence breast cancer risk, underpinning the benefit of endocrine therapies in the treatment of breast cancer. Modulation of their effects through ovarian ablation or chemoprevention strategies also significantly decreases breast cancer incidence. Conversely, there is an increased risk of breast cancer associated with pregnancy in the short term. The cellular mechanisms underlying these observations, however, are poorly defined. Here we demonstrate that mouse mammary stem cells (MaSCs) are highly responsive to steroid hormone signalling, despite lacking the oestrogen and progesterone receptors. Ovariectomy markedly diminished MaSC number and outgrowth potential in vivo, whereas MaSC activity increased in mice treated with oestrogen plus progesterone. Notably, even three weeks of treatment with the aromatase inhibitor letrozole was sufficient to reduce the MaSC pool. In contrast, pregnancy led to a transient 11-fold increase in MaSC numbers, probably mediated through paracrine signalling from RANK ligand. The augmented MaSC pool indicates a cellular basis for the short-term increase in breast cancer incidence that accompanies pregnancy. These findings further indicate that breast cancer chemoprevention may be achieved, in part, through suppression of MaSC function.
Asselin-Labat
Marie-Liesse
ML
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
Vaillant
François
F
Sheridan
Julie M
JM
Pal
Bhupinder
B
Wu
Di
D
Simpson
Evan R
ER
Yasuda
Hisataka
H
Smyth
Gordon K
GK
Martin
T John
TJ
Lindeman
Geoffrey J
GJ
Visvader
Jane E
JE
D000818:Animals; D001141:Aromatase / Q000378:metabolism; D047072:Aromatase Inhibitors / Q000494:pharmacology; D051927:CD24 Antigen / Q000378:metabolism; D002452:Cell Count; D066246:ErbB Receptors / Q000378:metabolism; D004967:Estrogens / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D006801:Humans; D019012:Integrin beta1 / Q000378:metabolism; D039661:Integrin beta3 / Q000378:metabolism; D000077289:Letrozole; D008321:Mammary Glands, Animal / Q000166:cytology*; D051379:Mice; D009570:Nitriles / Q000494:pharmacology; D010052:Ovariectomy; D019899:Paracrine Communication / Q000187:drug effects; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology; D011374:Progesterone / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D053245:RANK Ligand / Q000378:metabolism; D011960:Receptors, Estrogen / Q000172:deficiency; D011980:Receptors, Progesterone / Q000172:deficiency; D015398:Signal Transduction / Q000187:drug effects; D013234:Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D014230:Triazoles / Q000494:pharmacology
D047072:Aromatase Inhibitors; D051927:CD24 Antigen; D004967:Estrogens; D019012:Integrin beta1; D039661:Integrin beta3; D009570:Nitriles; D053245:RANK Ligand; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C505689:Tnfsf11 protein, mouse; D014230:Triazoles; D011374:Progesterone; D000077289:Letrozole; D001141:Aromatase; D066246:ErbB Receptors
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2196-201
16452162
Mol Cell Biol. 2006 Feb;26(3):1002-13
16428453
Nature. 2006 Feb 23;439(7079):993-7
16395311
J Biol Chem. 2003 Nov 14;278(46):46171-8
12952963
Lancet Oncol. 2008 Jan;9(1):45-53
18083636
Endocrinology. 2002 Jun;143(6):2357-65
12021201
Mol Cell Biol. 2007 Feb;27(4):1442-54
17145767
J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):3-13
15082914
J Clin Oncol. 2009 Jul 1;27(19):3235-58
19470930
Nature. 2006 Jan 5;439(7072):84-8
16397499
Genes Dev. 2003 May 15;17(10):1253-70
12756227
Nat Cell Biol. 2007 Feb;9(2):201-9
17187062
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9744-9
12897242
Dev Biol. 2009 Apr 1;328(1):127-39
19298785
Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):615-23
18971122
Cell. 2000 Sep 29;103(1):41-50
11051546
J Immunol Methods. 2009 Aug 15;347(1-2):70-8
19567251
N Engl J Med. 1994 Jul 7;331(1):5-9
8202106
Genes Dev. 2009 Nov 15;23(22):2563-77
19933147
Breast Cancer Res. 2004;6(5):213-8
15318928
Bioinformatics. 2005 May 1;21(9):2067-75
15657102
Lancet. 2005 May 14-20;365(9472):1687-717
15894097
Endocrinology. 2008 Dec;149(12):6236-50
18687774
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6965-70
9618522
J Natl Cancer Inst. 2006 Jul 19;98(14):1011-4
16849684
Nat Med. 2009 Aug;15(8):907-13
19648928
J Mammary Gland Biol Neoplasia. 2000 Jul;5(3):325-38
14973394
BMC Bioinformatics. 2006 May 19;7:261
16712727
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5076-81
9560231
N Engl J Med. 2001 Jan 25;344(4):276-85
11172156
Genes Dev. 1995 Sep 15;9(18):2266-78
7557380
Bioinformatics. 2007 Oct 15;23(20):2700-7
17720982
Genome Biol. 2004;5(10):R80
15461798
Epidemiol Rev. 1993;15(1):17-35
8405201
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5455-60
17369357
Obstet Gynecol. 2009 May;113(5):1027-1037
19384117
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809